跳至主要内容
临床试验/NCT05030922
NCT05030922进行中(未招募)不适用

Cardiovascular Risk Reduction-Diet in Pregnancy - Follow up 20 Years After the "CARRDIP"-Trial

Per Ole Iversen, MD2 个研究点 分布在 1 个国家目标入组 538 人开始时间: 2021年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
538
试验地点
2
主要终点
Cardiovascular health score

研究概览

简要总结

The "Cardiovascular Risk Reduction-Diet in Pregnancy" (CARRDIP) - is a randomised controlled trial with dietary intervention during pregnancy. The participants were enrolled in Norway 20 years ago and consisted of 269 pregnant, healthy mothers. The participants were randomised 1:1 to either intervention-diet or control. The intervention diet was build upon an anti-atherogenic principle and was a so called "Mediterranean diet". The participants were monitored during pregnancy, and mother and child participated in a follow-up study 1 year after birth. The current "CARRDIP20" trial is a follow-up of the same participants, both mother and offspring, 20 years after the original intervention to measure and analyse the cardiovascular health and compare the intervention group to the control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • from original CARRDIP-trial:
  • Non-smoking pregnant women
  • BMI 19 to 32 kg/m2 at inclusion
  • Age 21 to 38 years
  • Carrying a single foetus

排除标准

  • Previous pregnancy complications

研究组 & 干预措施

Diet intervention

Experimental

Follow up of both mother and offspring 20 years after allocation to an antiatherogenic diet during pregnancy.

干预措施: Antiatherogenic diet (Other)

Control

No Intervention

Follow up of both mother and offspring 20 years after allocation to control group during pregnancy.

结局指标

主要结局

Cardiovascular health score

时间窗: 1 day

Cardiovascular risk score by use of the most appropriate available risk score algorithm available at time of analysis, at present the preferred calculator is Life's Simple 7 - The American Heart Association https://doi.org/10.1161/CIRCULATIONAHA.109.192703

次要结局

  • Body fat percentage(1 day)
  • Ultrasound examination of liver(1 day)
  • Ultrasound examination of carotid artery(1 day)
  • Blood samples - Glukose metabolism(1 day)
  • Mean arterial pressure (MAP)(1 day)
  • Anthropometry(1 day)
  • Blood samples - Lipid profile(1 day)

研究者

发起方
Per Ole Iversen, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Per Ole Iversen, MD

Professor

University of Oslo

研究点 (2)

Loading locations...

相似试验